Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 10 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

10%

1 trials in Phase 3/4

Results Transparency

38%

3 of 8 completed with results

Key Signals

3 with results100% success

Data Visualizations

Phase Distribution

8Total

Not Applicable (2)

P 1 (3)

P 2 (2)

P 4 (1)

Trial Status

Completed8

Unknown2

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 8 completed trials

Clinical Trials (10)

Showing 10 of 10 trials

NCT02259218CompletedPrimary

Metabolomic and Epigenetic Profiling of Bodyfluids From Lung and Brain Cancer Receiving Radiation Therapy

NCT04553341Not ApplicableUnknownPrimary

Induction of Cortical Plasticity

NCT01024907Phase 1CompletedPrimary

Proton Beam Radiation Therapy in Treating Patients With Low Grade Gliomas

NCT03525080Not ApplicableCompleted

Comparison of 6-fluoro-[18F]-L-dihydroxyphenylalanine (18F-DOPA) Positron Emission Tomography (PET) and Multiparametric Resonance Magnetic Imagery (RMI) in Initial Exploration of Glial Tumors

NCT02193568Phase 4CompletedPrimary

Light Sedation or Intubated General Anesthesia in Patients With Brain Cancer Undergoing Craniotomy

NCT01172964Phase 1Completed

A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas

NCT00003537Phase 2CompletedPrimary

Antineoplaston Therapy in Treating Adult Patients With Anaplastic Astrocytoma

NCT00379080Phase 1CompletedPrimary

Tandutinib in Treating Patients With Recurrent or Progressive Glioblastoma

NCT01738646Phase 2Completed

Ph II SAHA and Bevacizumab for Recurrent Malignant Glioma Patients

NCT01806155UnknownPrimary

Prevalence of Post-craniotomy Headache in Siriraj Hospital

Showing all 10 trials